| name: | Pramiracetam | |
| ATC code: | N06BX16 | route: | oral | 
| compartments: | 1 | |
| dosage: | 600 | mg | 
| volume of distribution: | 0.7 | L | 
| clearance: | 4.79 | L/h | 
| other parameters in model implementation | ||
Pramiracetam is a synthetic nootropic compound in the racetam family, developed in the late 1970s. It is used for cognitive enhancement and has been studied for potential benefits in memory impairment and dementia; however, it is not approved by the FDA for use in the United States and is available as a prescription drug in a few countries such as Italy and some Eastern European countries.
Pharmacokinetic parameters in healthy adult volunteers (male and female), single oral administration.